Report error Found 15 Enz. Inhib. hit(s) with all data for entry = 11573
Affinity DataIC50: 5.50E+3nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 5.50E+4nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 5.50E+4nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 5.50E+4nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 5.50E+4nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:IC50 values were determined for compounds that covalently inhibit SARS-CoV-2 3CLpro using a recently described assay (Ghosh, A. K. et al. Bioorg. Med...More data for this Ligand-Target Pair
